Annual report [Section 13 and 15(d), not S-K Item 405]

Segment Information (Tables)

v3.25.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Information
The following table is a summary of segment information for Fiscal 2024 and 2023 (in thousands):
For the years ended
December 31, 2024 December 31, 2023
Net revenues
Diagnostic services $ —  $ 24,849 
Consumer products 6,770  10,135 
Consolidated net revenue 6,770  34,984 
Cost of revenue    
Diagnostic services 2,329  11,790 
Consumer products 4,591  7,638 
Consolidated cost of revenue 6,920  19,428 
Depreciation and amortization expense    
Diagnostic services 1,604  2,618 
Consumer products 4,583  3,432 
Total Depreciation and amortization expense 6,187  6,050 
Operating and other expenses
 Diagnostic services 15,928  12,245 
 Consumer products 4,484  7,533 
 Unallocated corporate 15,581  12,126 
 Total operating and other expenses 35,993  31,904 
Loss from operations, before income taxes    
Diagnostic services (19,861) (1,804)
Consumer products (6,888) (8,468)
Unallocated corporate (15,581) (12,126)
 Total loss from operations, before income taxes (42,330) (22,398)
Income tax (expense) benefit (7,195) 6,018 
 Net loss from continuing operations $ (49,525) $ (16,380)
The following table is a summary of segment information for Fiscal 2024 and Fiscal 2023 (in thousands):
December 31,
2024
December 31,
2023
ASSETS  
Diagnostic services $ 26,069  $ 44,221 
Consumer products 19,745  23,284 
Unallocated corporate 5,804  19,065 
 Assets held-for-sale 11,582  5,357 
Total assets $ 63,200  $ 91,927